Found 271 results
Author Keyword Title Type [ Year(Asc)]
Filters: Keyword is Humans  [Clear All Filters]
2007
Traber MG, Atkinson J.  2007.  Vitamin E, antioxidant and nothing more.. Free Radic Biol Med. 43(1):4-15.
2006
Taylor AW, Bruno RS, Frei B, Traber MG.  2006.  Benefits of prolonged gradient separation for high-performance liquid chromatography-tandem mass spectrometry quantitation of plasma total 15-series F-isoprostanes.. Anal Biochem. 350(1):41-51.
Myzak MC, Dashwood RH.  2006.  Chemoprotection by sulforaphane: keep one eye beyond Keap1.. Cancer Lett. 233(2):208-18.
Higdon JV, Frei B.  2006.  Coffee and health: a review of recent human research.. Crit Rev Food Sci Nutr. 46(2):101-23.
Lotito SB, Frei B.  2006.  Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: cause, consequence, or epiphenomenon? Free Radic Biol Med. 41(12):1727-46.
Myzak MC, Ho E, Dashwood RH.  2006.  Dietary agents as histone deacetylase inhibitors.. Mol Carcinog. 45(6):443-6.
Lotito SB, Frei B.  2006.  Dietary flavonoids attenuate tumor necrosis factor alpha-induced adhesion molecule expression in human aortic endothelial cells. Structure-function relationships and activity after first pass metabolism.. J Biol Chem. 281(48):37102-10.
Bruno RS, Leonard SW, Atkinson J, Montine TJ, Ramakrishnan R, Bray TM, Traber MG.  2006.  Faster plasma vitamin E disappearance in smokers is normalized by vitamin C supplementation.. Free Radic Biol Med. 40(4):689-97.
Myzak MC, Dashwood RH.  2006.  Histone deacetylases as targets for dietary cancer preventive agents: lessons learned with butyrate, diallyl disulfide, and sulforaphane.. Curr Drug Targets. 7(4):443-52.
Leonard SW, Traber MG.  2006.  Measurement of the vitamin E metabolites, carboxyethyl hydroxychromans (CEHCs), in biological samples.. Curr Protoc Toxicol. Chapter 7:Unit7.8.
Traber MG.  2006.  Relationship of vitamin E metabolism and oxidation in exercising human subjects.. Br J Nutr. 96 Suppl 1:S34-7.
Krueger SK, VanDyke JE, Williams DE, Hines RN.  2006.  The role of flavin-containing monooxygenase (FMO) in the metabolism of tamoxifen and other tertiary amines.. Drug Metab Rev. 38(1-2):139-47.
Myzak MC, Hardin K, Wang R, Dashwood RH, Ho E.  2006.  Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells.. Carcinogenesis. 27(4):811-9.
Dashwood RH.  2006.  Xenobiotic metabolism relevance to cancer.. J Nutr. 136(10):2681S-2S.

Pages